Print

 

FDA’s recent revocation of authorization of the color additive FD&C Red No. 3 represents a decisive shift in regulatory oversight and may cause massive disruptions in the food industry. This landmark decision, prompted by a 2022 citizen petition invoking the Delaney Clause, represents one of the most significant changes to food and color additive regulations in recent memory. For companies utilizing Red No. 3, the mandate to reformulate and comply with new requirements is both urgent and unavoidable.

The Weight of Compliance Deadlines

FDA has mandated food products must remove Red No. 3 by January 15, 2027, and ingested drugs must follow by January 18, 2028. Post-deadline, products containing this additive will be classified as adulterated under the Federal Food, Drug, and Cosmetic Act (FD&C Act), triggering enforcement actions such as:

Mandatory Recalls: Forcing companies to withdraw products from the market, often at great expense.

Import Refusals: Blocking non-compliant goods at U.S. borders, severely disrupting supply chains.

Financial Burden: Non-compliance could result in increased regulatory scrutiny and resulting delays, tarnishing corporate reputations, jeopardizing consumer trust, and impacting revenue.

Manufacturers are now racing against the clock to implement necessary changes and safeguard their market positions.

Importers also bear a heavy burden due to the ban. Their obligations include:

Verifying supplier documentation to confirm the absence of Red No. 3.

Maintaining rigorous oversight of suppliers under the Foreign Supplier Verification Program requirement

Failure to meet these obligations risks severe penalties, including detentions and refusals of imported goods.

Strategic Steps for Compliance

To navigate these compliance complexities and minimize operational disruptions, companies must take strategic steps with precision, foresight, and commitment to meeting both regulatory demands and consumer expectations.

Reformulation and Product Integrity

Reformulating products to eliminate Red No. 3 is not simple. Its unique properties and chemical structure complicate the search for suitable substitutes with the same vibrancy. Manufacturers must:

Engage in extensive testing of alternative color additives to ensure product consistency and consumer acceptance.

Anticipate increased production costs and potential delays due to the complexities of sourcing compliant ingredients.

Coordinate reformulation efforts across global operations, especially where Red No. 3 remains permitted in non-U.S. markets.

Label Updates and Packaging Synchronization

Removing Red No. 3 requires meticulous updates to ingredient labels and packaging. These updates must align with reformulated product launches, often requiring long lead times for design, approval, and production. Failing to coordinate these changes could lead to supply chain disruptions and consumer confusion.

Staying Ahead of Regulatory Change

To navigate this evolving landscape, companies must adopt a proactive compliance approach:

Monitor regulatory developments and public comment periods to anticipate changes.

Conduct regular internal audits to identify potential compliance gaps.

Leverage expert guidance to streamline reformulation and ensure timely adherence to FDA requirements.

By acting decisively, companies can achieve compliance while reinforcing their commitment to quality and trustworthiness. As the regulatory environment grows more stringent, proactive compliance is the key to sustaining market leadership and operational integrity.

Anna Benevente holds a Bachelor of Science degree in Biology from The College of William and Mary in Williamsburg, Virginia. Ms. Benevente has over 15 years of analytical research experience. As the Director of Product, Labeling, and Ingredient Review at Registrar Corp, she has been assisting companies with U.S. FDA regulations since 2009 and has researched thousands of products to determine whether they meet FDA requirements for compliance.